Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravenous Fish Oil Based Lipid Emulsion to Enhance Recovery in High-Risk Cardiac Surgery Patients: a Phase II Multicenter Trial - A Randomized, Placebo-controlled Trial -

NCT06279793 is registered in ClinicalTrials.gov with GCP-Service International West GmbH as lead sponsor.

NCT NCT06279793
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06279793 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravenous Fish Oil Based Lipid Emulsion to Enhance Recovery in High-Risk Cardiac Surgery Patients: a Phase II Multicenter Trial - A Randomized, Placebo-controlled Trial -
Lead sponsor
GCP-Service International West GmbH
Phase
Phase 2
Overall status
Recruiting
Start date
February 15, 2024
Completion date
September 30, 2030
Enrollment
550 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

adult patients ≥ 18 years, aortic surgical procedures, cardiopulmonary bypass, combined cardiac and aortic surgical procedures, combined cardiac procedures, combined valve and cabg, coronary artery bypass grafting (cabg), elective cardiac surgery, high risk patients, intensive care unit, multiple valve surgeries, valvular heart surgery